MedPath

Real World Study of Yiqifumai Prescription in Treating Heart Failure

Phase 2
Conditions
heart failure
Registration Number
ITMCTR2024000124
Lead Sponsor
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Meet the diagnostic criteria for heart failure;
Age =18 years old, gender unlimited;
NYHA cardiac function Grade II to IV

Exclusion Criteria

1.Complicated with acute myocardial infarction (within 2 months), constrictive pericarditis, acute cerebrovascular accident, acute myocarditis, cardiogenic shock, congenital heart disease, primary severe valvular disease, symptomatic hypotension, severe arrhythmia and hemodynamic changes;
2.There are serious endocrine diseases such as malignant tumor, severe hepatic and renal insufficiency, primary disease of blood system, or diabetes with serious complications, hyperthyroidism, etc.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath